Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: A case-control study

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Burwinkel, Barbara ^a   Shanmugam, Kalai S ^a   Hemminki, Kari ^a,b   Meindl, Alfons ^c   Schmutzler, Rita K ^d,e   Sutter, Christian ^f   Wappenschmidt, Barbara ^d,e   Kiechle, Marion ^c   Bartram, Claus R ^f   Frank, Bernd ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN D; GENE PRODUCT; MYC PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; WNT PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL CANCER; FEMALE; GENE MUTATION; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; NON INSULIN DEPENDENT DIABETES MELLITUS; ONCOGENE C MYC; PROTEIN EXPRESSION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE DOSAGE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 33845228965     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-268     Document Type: Article

References (17)

1. Nelson WJ, Nusse R: Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
2. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, et al.: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320-323.
3. van Vliet-Ostaptchouk JV, Shiri-Sverdlov R, Zhernakova A, Strengman E, van Haeften TW, Hofker MH, Wijmenga C: Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort. Diabetologia in press. 2006, Oct 10
4. Zhang C, Qi L, Hunter DJ, Meigs JB, Manson JE, van Dam RM, Hu FB: Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes 2006, 55:2645-2648.
5. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber T, Mandelker D, Leary RJ, Ptak J, Silliman N, et al.: The Consensus Coding Sequences of Human Breast and Colorectal Cancers. Science 2006, 314:268-274.
6. Wong NA, Pignatelli M: Beta-catenin - a linchpin in collorectal carcinogenesis? Am J Pathol 2002, 160:389-401.
7. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC: Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D I expression and cancer progression. Proc Natl Acad Sci U S A 2000, 97:4262-4266.
8. Cowin P, Rowlands TM, Hatsell SJ: Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005, 17:499-508.
9. Rowlands TM, Pechenkina IV, Hatsell SJ, Pestell RG, Cowin P: Dissecting the roles of beta-catenin and cyclin DI during mammary development and neoplasia. Proc Natl Acad Sci U S A 2003, 100:11400-11405.
10. Meindl A, the German Consortium for Hereditary Breast and Ovarian Cancer: Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 2002, 97:472-480.
11. Frank B, Hemminki K, Wappenschmidt B, Klaes R, Meindl A, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B: Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer. Int J Cancer 2006, 118:2917-2918.
12. Frank B, Hemminki K, Wirtenberger M, Bermejo JL, Bugert P, Klaes R, Schmutzler RK, Wappenschmidt B, Bartram CR, Burwinkel B: The rare ERBB2 variant lle654Val is associated with an increased familial breast cancer risk. Carcinogenesis 2005, 26:643-647.
13. Dupont WD, Plummer WD Jr: Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998, 19:589-601.
14. Houlston RS, Peto J: The future of association studies of common cancers. Hum Genet 2003, 112:434-435.
15. Antoniou AC, Easton DF: Polygenic inheritance of breast cancer: Implications for design of association studies. Genet Epidemiol 2003, 25:190-202.
16. Duval A, Gayet J, Zhou XP, lacopetta B, Thomas G, Hamelin R: Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res 1999, 59:4213-4215.
17. Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R: The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res 2000, 60:3872-3879.